these results suggest that dermatan sulphate is less haemorrhagic than heparin at equivalent antithrombotic doses , and that the haemorrhagic effect is associated with a glycosaminoglycan-induced platelet defect .
C0019134
heparin
C0017973
glycosaminoglycan